Bank of New York Mellon’s HOOKIPA Pharma HOOK Stock Holding History

Bank of New York Mellon’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,095	Closed	-$139K	–	4646
2022 Q1	$139K	Sell	6,095 -62	-1%	-$1.11K	﹤0.01%	4337
2021 Q4	$144K	Sell	6,157 -89	-1%	-$3.58K	﹤0.01%	4348
2021 Q3	$368K	Buy	6,246 +385	+7%	+$27.9K	﹤0.01%	3962
2021 Q2	$537K	Buy	5,861 +1,835	+46%	+$245K	﹤0.01%	3736
2021 Q1	$541K	Sell	4,026 -53	-1%	-$6.39K	﹤0.01%	3649
2020 Q4	$452K	Buy	4,079 +714	+21%	+$77.1K	﹤0.01%	3668
2020 Q3	$319K	Buy	3,365 +75	+2%	+$7.65K	﹤0.01%	3701
2020 Q2	$383K	Sell	3,290 -149	-4%	-$14.5K	﹤0.01%	3599
2020 Q1	$284K	Buy	3,439 +620	+22%	+$67.9K	﹤0.01%	3625
2019 Q4	$345K	Buy	2,819 +1,498	+113%	+$127K	﹤0.01%	3747
2019 Q3	$100K	Buy	+1,321	New	+$97.5K	﹤0.01%	4028

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon's HOOK Position: Q2 2022 in Review

Bank of New York Mellon sold out of HOOKIPA Pharma (HOOK) in Q2 2022, closing a stake of 6,095 shares — an estimated $139K sold.

Bank of New York Mellon first reported a position in HOOK in Q3 2019 and held it in 11 quarters. The position peaked at $541K in Q1 2021. 58 funds tracked by Wall St. Rank hold HOOK as of Q2 2022.

Bank of New York Mellon reported no remaining HOOKIPA Pharma position as of Q2 2022 after selling out during the quarter.
Bank of New York Mellon sold 6,095 HOOKIPA Pharma shares in Q2 2022, an estimated $139K.
Bank of New York Mellon first reported a position in HOOKIPA Pharma in Q3 2019 and held it in 11 quarters.
Bank of New York Mellon's HOOKIPA Pharma position peaked at $541K in Q1 2021.
58 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2022.

Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.